介入性心臟病学设备市场规模、份额、成长分析、按产品、按最终用户、按地区 - 行业预测，2024-2031 年

2022年，介入性心臟病学设备的全球市场规模为131亿美元，从2023年的140.6亿美元成长到2031年的247亿美元，预计在预测期内（2024-2031年）将成长。年增率为7.3%。

由于创新心血管设备的进步，介入性心臟病学设备市场正在显着成长。循环系统性心臟科医师是接受心血管疾病训练的专家，他们主要使用导管（促进血管成形术和置入术等微创手术的柔性管）。这些手术为患有各种心臟病（通常与高血压和糖尿病相关）的患者提供了开放性手术的可行替代方案。此外，这些设备还可以解决导致四肢动脉斑块积聚的周边血管问题。市场包括导管、球囊、支架、过滤器等。儘管轻鬆获得监管批准对市场扩张做出了积极贡献，但由于严格的政府法规和审批流程，挑战仍然存在，这可能会阻碍该行业的整体成长潜力。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析
• 贸易分析
• 原料分析

介入性心臟病学设备市场规模：依产品分类

• 市场概况
• 冠状动脉支架
  • 裸金属支架 (Bms)
  • 药物释放型支架 (Des)
  • 其他的
• 结构性心臟装置
  • 心臟瓣膜
  • 封堵器及其他
• 血管成形术用气球
• 导管
  • 诊断导管
  • 血管造影术检查
  • IVUS
  • 治疗导管
  • 切除术
  • 血栓切除术
  • 消融
• 栓塞防护装置

按最终用户分類的介入性心臟病学设备市场规模

• 市场概况
• 医院和 ASC
• 导尿实验室及其他

按地区分類的介入性心臟病学设备市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Medtronic PLC
• Terumo Corporation
• Biotronik SE & Co. KG
• Biosensors International Group Ltd
• ACIST Medical Systems
• Cardinal Health, Inc.
• Cook Medical Inc.
• Koninklijke Philips NV
• Edwards Lifesciences Corporation
• Nano Therapeutics Pvt. Ltd.
• AngioDynamics, Inc.
• Inari Medical, Inc.
• Genetesis, Inc.
• OptiMed Medical Instruments GmbH
• Meril Life Sciences Pvt. Ltd.
• OrbusNeich Medical

结论和建议

Global Interventional Cardiology Devices Market size was valued at USD 13.1 billion in 2022 and is poised to grow from USD 14.06 billion in 2023 to USD 24.7 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).

The market for interventional cardiology is seeing significant growth driven by advancements in innovative cardiovascular devices. Interventional cardiologists, trained specialists in cardiovascular diseases, primarily utilize catheters-flexible tubes that facilitate minimally invasive procedures like angioplasty and stenting. These techniques offer a viable alternative to open surgery for patients with various heart conditions, often associated with hypertension and diabetes. Additionally, these devices address peripheral vascular problems that lead to plaque build-up in limb arteries. Market offerings include catheters, balloons, stents, and filters. While the ease of obtaining regulatory licenses contributes positively to market expansion, challenges remain due to stringent government regulations and approval processes that may hinder overall growth potential in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Cardiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Cardiology Devices Market Segmental Analysis

Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Interventional Cardiology Devices Market

The global interventional cardiology devices market is primarily driven by the increasing prevalence of lifestyle habits such as high saturated fat intake, excessive salt consumption, alcohol use, and smoking, all of which contribute significantly to the risk of coronary artery disease (CAD). The rise in tobacco use and sedentary lifestyles further exacerbates this issue, leading to a growing incidence of obesity and CAD, thereby propelling the demand for interventional cardiology devices. As individuals become more aware of the health implications associated with these habits, there is a heightened need for advanced medical solutions, thus fostering growth in the interventional cardiology devices sector.

Restraints in the Global Interventional Cardiology Devices Market

The Global Interventional Cardiology Devices market faces significant restraints due to the evolving and complicated regulatory standards that govern medical device approvals. These regulations are influenced by various legal factors and are particularly challenging to navigate. Stringent scrutiny is required to ensure that medical devices meet high performance and quality benchmarks, which is essential for safeguarding public safety. Consequently, these rigorous and intricate certification processes may hinder the growth of the market, as manufacturers strive to comply with such demanding requirements while also trying to adapt to the changing needs of customers and the healthcare landscape.

Market Trends of the Global Interventional Cardiology Devices Market

The Global Interventional Cardiology Devices market is witnessing significant growth, driven primarily by the rising prevalence of obesity-related cardiovascular diseases and an increase in coronary artery disease due to unhealthy lifestyle choices. As sedentary lifestyles, smoking, and excessive alcohol consumption become more common, the demand for advanced interventional cardiology devices is surging. These devices offer cardiologists the ability to conduct life-saving procedures with improved safety and efficiency, minimizing complications. Consequently, the market is poised for expansion, fueled by technological advancements and an increasing focus on preventive and interventional cardiac care. As awareness grows, investment in innovative solutions will likely contribute to sustained market momentum.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Interventional Cardiology Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Coronary Stents
  • Bare-Metal Stent (Bms)
  • Drug-Eluting Stent (Des)
  • Others
• Structural Heart Devices
  • Heart Valves
  • Occluders & Others
• Angioplasty Balloons
• Catheters
  • Diagnostic Catheters
  • Angiography
  • Ivus
  • Treatment Catheters
  • Atherectomy
  • Thrombectomy
  • Ablation
• Embolic Protection Devices

Global Interventional Cardiology Devices Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals & Ascs
• Catheterization Labs & Others

Global Interventional Cardiology Devices Market Size & CAGR (2024-2031)

• North America (Product, End User)
  • USA
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACIST Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetesis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMed Medical Instruments GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations